DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
47 hedge funds and large institutions have $201M invested in Dicerna Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more funds holding
Funds holding: 40 → 47 (+7)
Holders
47
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$25M | |
| 2 | +$3.29M | |
| 3 | +$2.91M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$2.57M |
| 5 |
USAA
United Services Automobile Association
San Antonio,
Texas
|
+$782K |
Top Sellers
| 1 | -$30.9M | |
| 2 | -$7.14M | |
| 3 | -$1.71M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$871K |
| 5 |
JPMorgan Chase & Co
New York
|
-$779K |